Male Breast Reduction in Bakersfield CA
Breasts in males are called genycomastia, a Greek word meaning "breasts looking similar to women's". 40-60% of men have breasts; many conditions can cause this phenomenon like medication and medical problems (alcohol use, marihuana and steroids), but in most of the cases the reason is not known. It can damage self-confidence and self esteem, therefore breast reduction can help.
The ideal candidates for the operation are men with genicomastia for at least a year long who have developed chest muscles and elastic skin. The surgery is not recommended for overweight men who can't loose weight using diet and exercise.
In case of extra breast tissue the surgeon will remove it through an invisible cut around the nipple or below the breast fold. Sometimes extra fat also removed using this method; the canula used for suction of the fat is inserted through the cut already made. When there is extra skin needs to be removed, the procedure may leave bigger scars.
If the extra tissue is fat, liposuction is performed. The cuts, 5-7 millimeters long, are made at the margins of the breast, from below and from the side. Sometimes small cut is made around the nipple. You may feel a vibration sensation, but no pain, if the procedure is done using local anesthetics. In extreme cases when there is large amounts of fat and tissue extracted, the extra skin needs to be removed, then a drainage tube usually left to prevent fluid collection.
Finally, incisions are closed and pressure bandages are placed.
Every operation has its risks. The risks include infection, bleeding, fluid collection, breast asymmetry (that needs to be corrected in additional surgery), scars, nipple distortion and permanent color changes of the skin.
After the surgery you may feel uncomfortable, regardless of the technique used. It can be treated with painkillers. Swelling and hemorrhage may appear in the area, to reduce the swelling you'll be instructed to wear a tight bandage around the chest for several weeks day and night. The breast will reach their final size in 3 month or so. You'll be able to go back to work after a week or two. It is advised to restrain from sexual activity or physical efforts for at least 2 weeks, and any activity that may harm the chest for a month. It's important to avoid sunlight to your chest for 6 month to prevent color changes in the breast.
More Bakersfield info...
Bakersfield Buy Large shopping centers and strip malls are abundant. The Marketplace, near the CSU Bakersfield campus, is relatively upscale, while the Promenade area on Rosedale Highway is a sprawling collection of major retailers and restaurants. Two indoor malls also serve shoppers: the very popular Valley Plaza on Ming Avenue in the southwest, and the East Hills Mall in the northeast off of Highway 178. Small, locally-owned antique shops are found in the Chester Avenue area.
Bakersfield Get in Located near the juncture of Interstate 5 and California 99 near the southern end of the Central Valley. Fly in to Bakersfield's Meadows Field airport, or an airport bus terminal located downtown connects Bakersfield to LAX with 7 trips per day. Amtrak is another option, with a recently-built main terminal downtown.
Male Breast ReductionLatest Forum Posts...
- hi, are there any non-surgical procedures that can be done to reduce my man-breasts? it's kinda annoying and embarrassing.
Plastic Surgery News...
- Meta-analysis of data from controlled trials has found that in postmenopausal women with breast cancer, aromatase-inhibitor treatment is associated with a statistically significant but small increase in risk of cardiovascular events.
The authors note that the aromatase inhibitors are more effective than tamoxifen in the treatment of breast cancer; however reports suggest that they may be associated with a higher cardiovascular risk. This analysis aimed to clarify the risk to benefit balance for these drugs. The authors carried out a comprehensive search, mostly using specialist sources, for long-term (five year) randomised controlled trials of aromatase inhibitors against tamoxifen after surgery in women with breast cancer where data on cardiovascular adverse events were reported. From this data, they derived the event risk-ratios and absolute event rates with the two drug groups. Primary outcome was grade 3 and 4 cardiovascular adverse events.
The initial search located ten potentially relevant trials of which 7 (n=19,818) were eligible for the analysis. All had been published in full, and three had subsequent updates. On the primary outcome, there was an increased risk of 0.52% in the aromatase inhibitor arm compared to the tamoxifen arm; a risk ratio of 1.31 (95% CI, 1.07 to 1.60; P =0.007). Thromboembolic events were a secondary outcome, and these were less likely than in the tamoxifen arm (RR, 0.53; 95% CI, 0.42 to 0.65; P <0.0001).
The authors conclude that treatment with aromatase inhibitors is associated with a small increase in risk of cardiovascular adverse events - while this is statistically significant, the number needed to harm is around 160 to 180. It may be balanced by a reduced risk of thromboembolic events.
- The Queensland and Northern New South Wales Lions Medical Research Foundation, long time supporters of the Brisbane research community, have confirmed funding of $1.2 million for scientists at UQ's Diamantina Institute. Dr Gethin Thomas will be the inaugural recipient of the $300,000 three-year fellowship, which will fund his research investigating the causes of ankylosing spondylitis (AS).